You Will Write A 3-4 Page Research-Based Paper In Current AP

You Will Write A 3 4 Page Research Based Paper In Current Apa Format T

You will write a 3-4 page research-based paper in current APA format that focuses on an infectious disease selected from the list below. Explain the pathogen, mode of transmission, common signs and symptoms, prevention, and treatment for the disease. The paper must include at least 2 scholarly references in addition to the Bible.

Paper Topic Options: Hepatitis A, Influenza, Hepatitis B, Rotavirus, Tuberculosis, Hepatitis C, HIV, STD, Ebola.

Paper For Above instruction

The selected infectious disease for this research paper is hepatitis B, a significant global health concern due to its high prevalence and potential for chronic health issues. This paper will explore the pathogen responsible for hepatitis B, its mode of transmission, typical signs and symptoms, prevention strategies, and treatment options, supported by scholarly sources and contextualized within biblical principles concerning health and healing.

Introduction

Hepatitis B virus (HBV) infection remains a critical public health challenge worldwide, affecting approximately 296 million individuals according to the World Health Organization (WHO, 2023). As a contagious liver infection leading to both acute and chronic disease, understanding its nature is essential for effective prevention and management. This paper aims to provide a comprehensive overview of HBV, including its pathogen, transmission methods, clinical presentation, preventive measures, and available treatments, underscoring the importance of education and community health initiatives.

The Pathogen

Hepatitis B is caused by the hepatitis B virus, a partially double-stranded DNA virus belonging to the Hepadnaviridae family (Seeger & Mason, 2015). The virus exhibits a unique replication cycle involving reverse transcription, similar to retroviruses, which contributes to its persistence and difficulty in eradication. Structurally, HBV has an outer envelope composed of surface antigens (HBsAg), and an inner core containing the viral DNA and nucleocapsid proteins (Lopez et al., 2020). The virus infects hepatocytes in the liver, causing inflammation and, in some cases, progressing to cirrhosis or hepatocellular carcinoma if left untreated.

Mode of Transmission

HBV primarily spreads through exposure to infected bodily fluids such as blood, semen, and vaginal secretions. Common routes include unprotected sexual contact, sharing of contaminated needles or syringes among intravenous drug users, and perinatal transmission from mother to child during childbirth (Schweitzer et al., 2015). Additionally, unsafe medical practices, including inadequate sterilization of equipment and transfusions with unscreened blood products, can facilitate the spread of HBV. Unlike some other viruses, HBV is notably resilient in the environment, capable of surviving on surfaces for extended periods, which contributes to its transmissibility.

Signs and Symptoms

Acute hepatitis B infection often presents with a spectrum of clinical manifestations, ranging from asymptomatic cases to severe illness. Common signs include jaundice (yellowing of the skin and eyes), fatigue, abdominal pain, nausea, vomiting, and dark urine (Lok & McMahon, 2020). In some cases, individuals may experience fever, joint pain, and loss of appetite. Notably, many infected infants and children may remain asymptomatic but remain carriers of the virus, posing a risk for further transmission. Chronic HBV infection, which affects approximately 5-10% of adult cases, can be silent for years but eventually lead to liver cirrhosis and hepatocellular carcinoma (WHO, 2023).

Prevention

Prevention strategies are critical in controlling HBV infection. The hepatitis B vaccine, introduced in the 1980s, is highly effective, providing over 95% immunity after a complete series of three doses (CDC, 2021). Vaccination is recommended for all infants, unvaccinated children, and high-risk adults, including healthcare workers and intravenous drug users. Additionally, practicing safe sex using barrier methods, avoiding shared needles, and ensuring proper sterilization of medical equipment are essential preventive measures. Pregnant women are routinely screened for HBV, and infants born to infected mothers receive immunoglobulin and vaccination promptly to reduce the risk of perinatal transmission (Lok & McMahon, 2020).

Treatment

While there is no definitive cure for hepatitis B, antiviral medications can manage the infection effectively. The primary goal of treatment is to suppress viral replication, reduce liver inflammation, and prevent progression to cirrhosis and liver cancer. Nucleos(t)ide analogs such as tenofovir and entecavir are first-line therapies for chronic HBV infection due to their efficacy and safety profiles (Chen et al., 2016). For acute HBV infection, supportive care is generally sufficient, as most cases resolve spontaneously. Regular monitoring of liver function and viral load is essential for patients with chronic infection to guide treatment decisions and assess disease progression. In some cases, interferon-alpha is used to stimulate the immune response against the virus, although its side effects limit widespread use (Lok & McMahon, 2020).

Biblical Perspective on Healing and Prevention

In the biblical context, health and healing are often intertwined with faith and divine intervention. Scriptures such as James 5:14-15 emphasize prayer for the sick and the importance of medical treatment, indicating a holistic approach to health: "Is anyone among you sick? Let them call the elders of the church to pray over them and anoint them with oil in the name of the Lord." This perspective underscores the value of prayer alongside medical advancements like vaccines and antiviral treatments. Additionally, the Bible advocates for cleanliness and avoidance of behaviors that lead to spiritual and physical harm, resonating with modern preventative measures like vaccination and safe practices to combat infectious diseases such as hepatitis B.

Conclusion

Hepatitis B remains a formidable infectious disease with significant health implications worldwide. Understanding its pathogen, modes of transmission, clinical signs, preventative strategies, and treatment options is vital for reducing its burden. Vaccination remains the most effective preventive measure, complemented by safe practices and medical management for those infected. Biblical principles emphasizing healing and prevention can serve as a moral framework supporting public health initiatives aimed at eradicating hepatitis B and promoting overall community wellness.

References

  • Centers for Disease Control and Prevention (CDC). (2021). Hepatitis B vaccination. https://www.cdc.gov/hepatitis/hbv/vaccination.htm
  • Chen, C. J., Yang, H. I., Iloeje, U. H. (2016). Hepatitis B virus: the influence of host and viral factors on disease progression. Journal of Viral Hepatitis, 23(4), 273–278.
  • Lopez, L. I., et al. (2020). Structural biology of hepatitis B virus. Virology Journal, 17(1), 151.
  • Lok, A. S. F., & McMahon, B. J. (2020). Chronic Hepatitis B: Update 2019. Hepatology, 71(2), 687–721.
  • Seeger, C., & Mason, W. S. (2015). Molecular biology of hepatitis B virus infection. Virology, 479-480, 672–686.
  • Schweitzer, A., et al. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet, 386(10003), 1546–1555.
  • World Health Organization (WHO). (2023). Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

Related Assignments